Abstract
Colorectal cancer is the third most common cancer in the United States and the liver
is the most common site of metastatic disease. The presence and extent of hepatic
metastases are a major prognostic indicator. Although surgical resection is the accepted
first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are
eligible for resection due to the extent and location of disease. This article discusses
the current role of transarterial therapies in the treatment of colorectal liver metastases.
Keywords
interventional radiology - cTACE - DEBIRI - radioembolization - colorectal liver metastases
